Pancreatic Cancer Research

ResearcherGuiyang Medical UniversityActive in the last 2 years

Yue Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6612-8002; OpenAlex author ID A5100333740. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: 2 papers

Papers 7

  1. Shikonin reverses cancer-associated fibroblast-induced gemcitabine resistance in pancreatic cancer cells by suppressing monocarboxylate transporter 4-mediated … Co-author DOI 10.1016/j.phymed.2023.155214↗
  2. IL15RA-STAT3-GPX4/ACSL3 signaling leads to ferroptosis resistance in pancreatic cancer. Co-author DOI 10.3724/abbs.2024153↗
  3. PITX2 in pancreatic stellate cells promotes EMT in pancreatic cancer cells via the Wnt/β-catenin pathway. Co-author DOI 10.3724/abbs.2023118↗
  4. A positive feedback loop of ARF6 activates ERK1/2 signaling pathway via DUSP6 silencing to promote pancreatic cancer progression. First author DOI 10.3724/abbs.2022111↗
  5. Agmatinase facilitates the tumorigenesis of pancreatic adenocarcinoma through the TGFβ/Smad pathway. Co-author DOI 10.3892/etm.2022.11417↗
  6. CCL26 is upregulated by nab-paclitaxel in pancreatic cancer-associated fibroblasts and promotes PDAC invasiveness through activation of the PI3K/AKT/mTOR pathw… Co-author DOI 10.1093/abbs/gmab032↗
  7. FUBP1 mediates the growth and metastasis through TGFβ/Smad signaling in pancreatic adenocarcinoma. Co-author DOI 10.3892/ijmm.2021.4899↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaowu Xu · 3 shared papers, 2022–2024 · strength 0.52
  2. Di Wu · 3 shared papers, 2021–2024 · strength 0.51
  3. Yi Qin · 2 shared papers, 2023–2024 · strength 0.38
  4. Xuemin Chen · 2 shared papers, 2022–2024 · strength 0.35
  5. Xingxing Zhang · 2 shared papers, 2021–2022 · strength 0.31
  6. Xuemin Chen · 2 shared papers, 2021–2023 · strength 0.31
  7. Xianjun Yu · 1 shared paper, 2024 · strength 0.20
  8. Zhiliang Wang · 1 shared paper, 2024 · strength 0.20
  9. Xiaoxia Hu · 1 shared paper, 2024 · strength 0.19
  10. Yan Chen · 1 shared paper, 2024 · strength 0.19
  11. Yang Yang · 1 shared paper, 2023 · strength 0.18
  12. Jinlian Chen · 1 shared paper, 2022 · strength 0.17
  13. Zekun Lu · 1 shared paper, 2022 · strength 0.15
  14. Bingkai Xiao · 1 shared paper, 2022 · strength 0.15
  15. Xin Xing · 1 shared paper, 2021 · strength 0.14
  16. Xiaoying Zhang · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.